- Home
- PBYI vs RELL Comparison
PBYI vs RELL Comparison
Compare PBYI & RELL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- RELL
- Stock Information
- Founded
- PBYI 2010
- RELL 1947
- Country
- PBYI United States
- RELL United States
- Employees
- PBYI N/A
- RELL N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- RELL Electronic Components
- Sector
- PBYI Health Care
- RELL Technology
- Exchange
- PBYI Nasdaq
- RELL Nasdaq
- Market Cap
- PBYI 171.7M
- RELL 139.9M
- IPO Year
- PBYI N/A
- RELL N/A
- Fundamental
- Price
- PBYI $4.64
- RELL $10.01
- Analyst Decision
- PBYI Strong Buy
- RELL
- Analyst Count
- PBYI 1
- RELL 0
- Target Price
- PBYI $7.00
- RELL N/A
- AVG Volume (30 Days)
- PBYI 648.1K
- RELL 39.9K
- Earning Date
- PBYI 11-06-2025
- RELL 10-08-2025
- Dividend Yield
- PBYI N/A
- RELL 2.40%
- EPS Growth
- PBYI 434.29
- RELL N/A
- EPS
- PBYI 0.97
- RELL N/A
- Revenue
- PBYI $238,062,000.00
- RELL $208,909,000.00
- Revenue This Year
- PBYI N/A
- RELL $3.90
- Revenue Next Year
- PBYI N/A
- RELL $15.83
- P/E Ratio
- PBYI $4.76
- RELL N/A
- Revenue Growth
- PBYI 8.63
- RELL 6.34
- 52 Week Low
- PBYI $2.32
- RELL $7.57
- 52 Week High
- PBYI $6.07
- RELL $15.51
- Technical
- Relative Strength Index (RSI)
- PBYI 49.99
- RELL 54.69
- Support Level
- PBYI $4.49
- RELL $9.48
- Resistance Level
- PBYI $5.22
- RELL $9.95
- Average True Range (ATR)
- PBYI 0.26
- RELL 0.28
- MACD
- PBYI -0.12
- RELL 0.02
- Stochastic Oscillator
- PBYI 22.33
- RELL 86.36
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About RELL Richardson Electronics Ltd.
Richardson Electronics Ltd provides engineered solutions, power grid, and microwave tubes and related consumables, power conversion, RF and microwave components, high-value flat panel detector solutions, replacement parts, tubes, and service training for diagnostic imaging equipment and customized display solutions. Its products have applications in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. The company segments include PMT (Power and Microwave Technologies Group), Canvys, (Green Energy Solutions) GES, and Healthcare reportable segments. The company derives the majority of its revenues from the PMT segment.